Impact of SMOFlipid emulsion integration in total parenteral nutrition on inpatient outcomes and economic burden for preterm neonates: a retrospective cohort study

Table 4 Effect of using TPN with SMOFlipid on sepsis, LOS, and total cost among a cohort of preterm infants after IPSW

Variables	TPN with SMOFlipid	TPN without SMOFlipid	Estimate	95% CI		P
				Lower	Upper
Sepsis	13 (12.6%)	16 (18.3%)	0.64	0.272	1.51	0.305
LOS (Days)	29.3 (9.5)	33.4 (20.1)	− 4.12	− 7.58	0.14	0.080
Total cost (EGP)	32951 (11249)	39254 (25499)	− 6396	− 11,546	− 1491	0.034*

Sepsis is expressed as frequency and percentage. LOS and total cost are expressed as the mean and standard deviation. Estimate: represent the odds ratio (SMOFlipid vs. No SMOFlipid) for sepsis and the gamma regression coefficient (difference between SMOFlipid and no SMOFlipid) for LOS and total cost

ISSN: 1471-2431